A randomised controlled trial investigating ventilation imaging to improve the quality of life for patients with lung cancer treated with radiation therapy VITaL

This trial is testing a new treatment planning method for patients with lung cancer who will be treated with radiation therapy. This new method is called Computed Tomography (CT) ventilation imaging. It aims to help protect the healthiest parts of patient's lungs from being injured by the radiation therapy. The investigators will determine whether healthy lung sparing can improve the quality of life in these patients.


For more information about VITaL visit: https://image-x.sydney.edu.au/the-vital-clinical-trial/

Primary Sponsor

The University of Sydney

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Accrual Target

165

Trial Chairperson

Prof Paul Keall, Image X Institute, NSW, Australia

Trial Contact

qa@trog.com.au

Clinical Trial Registration

Related Post

21 October, 2026

Jess’s deeply personal reason for joining TROG’s Km’s for Cancer Research challenge

LATEST NEWS: 21 October 2026 For Jess Synge, taking

14 October, 2026

New FET-PET imaging approach helps target radiotherapy for glioblastoma, FIG trial – TROG 18.06 finds

LATEST NEWS: 14 October 2026 Adding a FET-PET brain